Funding for this research was provided by:
Buchanan Charitable Foundation Doctoral Scholarship
C.R.G holds the W&B Hadden Chair in Ophthalmology.
Manatu Hauora | Health Research Council of New Zealand (13/692)
Safe Sight Society of New Zealand
Article History
Received: 26 February 2018
Accepted: 13 July 2018
First Online: 26 July 2018
Competing Interests
: C.R.G. is a founding scientist of OcuNexus Therapeutics, Inc. (USA) (and previously CoDa Therapeutics, Inc.) which has intellectual property related to the regulation of connexin channels in the treatment of ocular and other disease. The authors hold two New Zealand provisional patents and have filed a PCT application with regards to Xentry fusion peptides for modulation of connexin gap junction and hemichannel activity.